European drug report 2013

Annual overview of the European drug situation, published by the European Monitoring Centre for Drugs and Drug Addiction on 28 May 2013.

Central to the European Drug Report package is the report on trends and developments (Please click on Related Url). The accompanying Perspectives on drugs provide deeper insights into important issues, which this year include new treatment approaches for hepatitis C, high-risk cannabis use and the control of increasingly available new psychoactive substances. Additional layers to the package are provided by the Statistical bulletin and Country overviews, where national-level data and analysis can be found.

[The European Drug Report published in 2013 replaced what used to be called Annual report on the state of the drugs problem in Europe last published in 2012]

• Primary Source

EMCDDA: News Release: No.6, 2013 (28.05.13): New European drug report out today — Europe’s drugs problem in ‘state of flux’ http://www.emcdda.europa.eu/news/2013/6

EMCDDA: News Release: No.7, 2013 (28.05.13): Record levels of treatment, but still a need to invest in new interventions and social reintegration http://www.emcdda.europa.eu/news/2013/7

EMCDDA: European drug report 2013: Trends and developments http://www.emcdda.europa.eu/publications/edr/trends-developments/2013

Spiegel Online International, 28.05.13: 'Legal Highs': New Synthetic Drugs Flood EU Market http://www.spiegel.de/international/europe/eu-report-shows-spike-in-new-synthetic-drugs-a-902394.html

BBC News, 28.05.13: More 'legal highs' available in EU, says drug agency http://www.bbc.co.uk/news/world-europe-22697505

---